COVID-19 stroke apical lung examination study: a diagnostic and prognostic imaging biomarker in suspected acute stroke
No Thumbnail Available
Authors
Siddiqui, J.
Bala, F.
Sciacca, S.
Falzon, A.M.
Benger, M.
Matloob, S.A.
Miller, F.N.A.C.
Simister, R.J.
Chatterjee, I.
Sztriha, L.K.
Check for full-text access
Issue Date
2021
Type
Article
Language
Keywords
Alternative Title
Abstract
BACKGROUND AND PURPOSE: Diagnosis of coronavirus disease 2019 (COVID-19) relies on clinical features and reverse-transcriptase polymerase chain reaction testing, but the sensitivity is limited. Carotid CTA is a routine acute stroke investigation and includes the lung apices. We evaluated CTA as a potential COVID-19 diagnostic imaging biomarker. MATERIALS AND METHODS: This was a multicenter, retrospective study ( RESULTS: Apical ground-glass opacification was present in 22.2% (50/225) of patients. Ground-glass opacification had high interrater reliability (Fleiss κ = 0.81; 95% CI, 0.68-0.95) and, compared with reverse-transcriptase polymerase chain reaction, had good diagnostic performance (sensitivity, 75% [95% CI, 56-87]; specificity, 81% [95% CI, 71-88]; OR = 11.65 [95% CI, 4.14-32.78]; CONCLUSIONS: We identified a simple, reliable, and accurate COVID-19 diagnostic and prognostic imaging biomarker obtained from CTA lung apices: the presence or absence of ground-glass opacification. Our findings have important implications in the management of patients presenting with suspected stroke through early identification of COVID-19 and the subsequent limitation of disease transmission.
Description
Citation
Publisher
License
Journal
American Journal of Neuroradiology
Volume
42
Issue
1